Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

Clinical trial NCT05776862 · COMPLETED

Trial details

NCT number: NCT05776862
Sponsor: University of Miami
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injuries Tetraplegia Paraplegia Muscle Loss Atrophy, Muscular Insulin Resistance

Start date: 2023-03-27
Primary completion: 2025-01-29
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.